Cell Proliferation, EarlyView.Elucidating the contribution of gut‐organ axes will provide new insights for developing combined therapeutic strategies against sepsis‐associated multiple organ dysfunction. ABSTRACT Sepsis, a life‐threatening clinical syndrome precipitated by a maladaptive host response to infection, is associated with substantial morbidity and high mortality rates ...
Yichen Bao +7 more
wiley +1 more source
The burden of diabetic foot ulcers in a multi‐ethnic Asian cohort
Diabetic Medicine, EarlyView.Abstract Aims Diabetic foot ulcers (DFUs) are a major source of morbidity among individuals with diabetes mellitus (DM), imposing a substantial burden on healthcare systems. Our institution established a multidisciplinary service aiming to facilitate early specialist intervention for DFU management.
Zongwen Wee +2 more
wiley +1 more source
The Role of Glucagon-like Peptide-1 in the Pathophysiology of Heart Failure: A Special Focus. [PDF]
Card Fail RevRakisheva A, Zatsarinnyy A.
europepmc +1 more source
Glucagon-like peptide-1 agonists usage to widen the living donor pool for liver transplantation: A novel metabolic strategy. [PDF]
World J TransplantAlnagar A +6 more
europepmc +1 more source
Glucagon-like Peptide-1 Receptor Agonists in Rheumatoid Arthritis: A Scoping Review of Metabolic, Anti-Inflammatory, and Cardioprotective Effects. [PDF]
J Pers MedBuonanno S +5 more
europepmc +1 more source
Glucagon-Like Peptide-1 Agonist vs. Placebo and Pulmonary Decline After Open-Heart Surgery: A Substudy of the GLORIOUS Randomised Clinical Trial. [PDF]
Acta Anaesthesiol ScandMikkelsen AD +9 more
europepmc +1 more source
The Trojan horse of off-label glucagon-like peptide-1 receptor agonist use: Protecting patients through responsible practice. [PDF]
J Int Med ResBelančić A, Jelaković B.
europepmc +1 more source
Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists in Parkinson Disease: A Systematic Review and Meta-Analysis. [PDF]
Brain BehavRaza H +11 more
europepmc +1 more source